162 related articles for article (PubMed ID: 20372069)
1. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
Hussenet T; du Manoir S
Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
[TBL] [Abstract][Full Text] [Related]
2. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
3. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
[TBL] [Abstract][Full Text] [Related]
4. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
Mukhopadhyay A; Berrett KC; Kc U; Clair PM; Pop SM; Carr SR; Witt BL; Oliver TG
Cell Rep; 2014 Jul; 8(1):40-9. PubMed ID: 24953650
[TBL] [Abstract][Full Text] [Related]
5. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
[TBL] [Abstract][Full Text] [Related]
6. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
Bass AJ; Watanabe H; Mermel CH; Yu S; Perner S; Verhaak RG; Kim SY; Wardwell L; Tamayo P; Gat-Viks I; Ramos AH; Woo MS; Weir BA; Getz G; Beroukhim R; O'Kelly M; Dutt A; Rozenblatt-Rosen O; Dziunycz P; Komisarof J; Chirieac LR; Lafargue CJ; Scheble V; Wilbertz T; Ma C; Rao S; Nakagawa H; Stairs DB; Lin L; Giordano TJ; Wagner P; Minna JD; Gazdar AF; Zhu CQ; Brose MS; Cecconello I; Ribeiro U; Marie SK; Dahl O; Shivdasani RA; Tsao MS; Rubin MA; Wong KK; Regev A; Hahn WC; Beer DG; Rustgi AK; Meyerson M
Nat Genet; 2009 Nov; 41(11):1238-42. PubMed ID: 19801978
[TBL] [Abstract][Full Text] [Related]
7. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
9. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
10. SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.
Kim BR; Van de Laar E; Cabanero M; Tarumi S; Hasenoeder S; Wang D; Virtanen C; Suzuki T; Bandarchi B; Sakashita S; Pham NA; Lee S; Keshavjee S; Waddell TK; Tsao MS; Moghal N
PLoS Biol; 2016 Nov; 14(11):e1002581. PubMed ID: 27880766
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
12. SOX2 and squamous cancers.
Porter L; McCaughan F
Semin Cancer Biol; 2020 Dec; 67(Pt 1):154-167. PubMed ID: 32905832
[TBL] [Abstract][Full Text] [Related]
13. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
14. Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.
Kim BR; Coyaud E; Laurent EMN; St-Germain J; Van de Laar E; Tsao MS; Raught B; Moghal N
Mol Cell Proteomics; 2017 Oct; 16(10):1864-1888. PubMed ID: 28794006
[TBL] [Abstract][Full Text] [Related]
15. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
Brustmann H; Brunner A
Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
[TBL] [Abstract][Full Text] [Related]
17. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
[TBL] [Abstract][Full Text] [Related]
18. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
[TBL] [Abstract][Full Text] [Related]
19. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
